John Finnie

5.2k total citations · 1 hit paper
156 papers, 3.7k citations indexed

About

John Finnie is a scholar working on Molecular Biology, Neurology and Neurology. According to data from OpenAlex, John Finnie has authored 156 papers receiving a total of 3.7k indexed citations (citations by other indexed papers that have themselves been cited), including 44 papers in Molecular Biology, 43 papers in Neurology and 26 papers in Neurology. Recurrent topics in John Finnie's work include Traumatic Brain Injury and Neurovascular Disturbances (25 papers), Botulinum Toxin and Related Neurological Disorders (15 papers) and Clostridium difficile and Clostridium perfringens research (14 papers). John Finnie is often cited by papers focused on Traumatic Brain Injury and Neurovascular Disturbances (25 papers), Botulinum Toxin and Related Neurological Disorders (15 papers) and Clostridium difficile and Clostridium perfringens research (14 papers). John Finnie collaborates with scholars based in Australia, United States and United Kingdom. John Finnie's co-authors include Jim Manavis, Peter Blumbergs, Val Gebski, Antony Basten, Michael H. Repacholi, Alan W. Harris, Peter L. Reilly, B. Vernon‐Roberts, Prashanthan Sanders and Nigel R. Jones and has published in prestigious journals such as Journal of Clinical Investigation, Journal of the American College of Cardiology and PLoS ONE.

In The Last Decade

John Finnie

153 papers receiving 3.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Electrophysiological, Electroanatomical, and Structural Remodeling of the Atria as Consequences of Sustained Obesity

2015 305 citations Jim Manavis, John Finnie et al. profile →

Peers

Countries citing papers authored by John Finnie

Since Specialization

Citations

This map shows the geographic impact of John Finnie's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John Finnie with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John Finnie more than expected).

Fields of papers citing papers by John Finnie

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John Finnie. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John Finnie. The network helps show where John Finnie may publish in the future.

Co-authorship network of co-authors of John Finnie

This figure shows the co-authorship network connecting the top 25 collaborators of John Finnie. A scholar is included among the top collaborators of John Finnie based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with John Finnie. John Finnie is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	An immunocompetent rat model of Mycobacterium abscessus multinodular granulomatous lung infection 2025 ·Tuberculosis ·(unknown), Clare Cooksley, (unknown), (unknown), John Finnie, (unknown), (unknown), Mahnaz Ramezanpour, Alkis J. Psaltis, Peter‐John Wormald, Patricia Cmielewski, Alexandra McCarron, Martin Donnelley, David Parsons, Sarah Vreugde	2
2	Striking and widespread microglial activation in the brains of Southdown lambs with type II glucocerebrosidosis (neuronopathic Gaucher disease) 2024 ·Journal of Comparative Pathology ·John Finnie, Kim M. Hemsley, Jim Manavis, Helen Beard, John Brealey, Thomas Robertson, Peter Blumbergs	0
3	Lipid nanoparticles and transcranial focused ultrasound enhance the delivery of SOD1 antisense oligonucleotides to the murine brain for ALS therapy 2024 ·Journal of Controlled Release ·(unknown), Amal J. Sivaram, Gary Cowin, (unknown), Luke McAlary, Jeremy S. Lum, Nicholas L. Fletcher, (unknown), Joshua D. Simpson, Liyu Chen, Joanna M. Wasielewska, Edward Byrne, John Finnie, Jim Manavis, Anthony R. White, Justin J. Yerbury, Kristofer J. Thurecht, Kara L. Vine	10
4	Staphylococcus aureus Biofilm-Secreted Factors Cause Mucosal Damage, Mast Cell Infiltration, and Goblet Cell Hyperplasia in a Rat Rhinosinusitis Model 2024 ·International Journal of Molecular Sciences ·Ghais Houtak, Roshan Nepal, George Bouras, (unknown), Catherine Bennett, John Finnie, Kevin Fenix, Alkis J. Psaltis, Peter‐John Wormald, Sarah Vreugde	6
5	Preclinical and clinical evaluation through serial colonoscopic evaluation of neratinib‐induced diarrhea in HER2‐positive breast cancer—A pilot study 2024 ·Physiological Reports ·Joanne M. Bowen, Sofía Braga, (unknown), John Finnie, (unknown), Blaire Cooke, G. Bischof, Alvin Wong, (unknown)	4
6	Cep55 regulation of PI3K/Akt signaling is required for neocortical development and ciliogenesis 2021 ·PLoS Genetics ·(unknown), Belal Shohayeb, Amanda L. Bain, Patrick R.J. Fortuna, Debottam Sinha, Andrew Burgess, Richard J. Mills, (unknown), J. Alejandro López, Peter Blumbergs, John Finnie, Murugan Kalimutho, Michael Piper, James E. Hudson, Dominic C.H. Ng, Kum Kum Khanna	3
7	The immunotoxicity, but not anti-tumor efficacy, of anti-CD40 and anti-CD137 immunotherapies is dependent on the gut microbiota 2021 ·Cell Reports Medicine ·Stephen J. Blake, (unknown), Feargal J. Ryan, José A. Caparrós‐Martín, Georgina L. Eden, (unknown), (unknown), Saoirse C. Benson, Damon J. Tumes, (unknown), Natalie E. Stevens, John Finnie, Hiroki Kobayashi, Deborah L. White, Steve Wesselingh, Fergal O’Gara, Miriam A. Lynn, David J. Lynn	26
8	Phenotypic Characterization and Comparison of Cystic Fibrosis Rat Models Generated Using CRISPR/Cas9 Gene Editing 2020 ·American Journal Of Pathology ·Alexandra McCarron, Patricia Cmielewski, (unknown), Chantelle McIntyre, John Finnie, Fiona E. Craig, Nathan Rout-Pitt, Juliette Delhove, John E. Schjenken, Hon Y. Chan, (unknown), Emma Knight, Rodney C. Gilmore, Wanda K. O’Neal, Richard C. Boucher, David Parsons, Martin Donnelley	30
9	A Novel Rat Model to Test Intra-Abdominal Anti-adhesive Therapy 2020 ·Frontiers in Surgery ·(unknown), (unknown), Ahmed Bassiouni, Matthew H. Smith, John Finnie, Markus Trochsler, Alkis J. Psaltis, Sarah Vreugde, Peter J. Wormald	10
10	Pericytes, inflammation, and diabetic retinopathy 2019 ·Inflammopharmacology ·(unknown), (unknown), (unknown), Jamie E. Craig, John Finnie	87
11	Targeting neratinib-induced diarrhea with budesonide and colesevelam in a rat model 2018 ·Cancer Chemotherapy and Pharmacology ·Kate R. Secombe, (unknown), (unknown), Anthony Wignall, John Finnie, Dorothy Keefe, Francesca Avogadri-Connors, Elizabeth Olek, (unknown), Susan Moran, Joanne M. Bowen	11
12	Loss of Endothelial Barrier Antigen Immunoreactivity in Rat Retinal Microvessels is Correlated with Clostridium perfringens Type D Epsilon Toxin-induced Damage to the Blood–Retinal Barrier 2017 ·Journal of Comparative Pathology ·(unknown), John Finnie	9
13	Temporal Sequence of Autolysis in the Cerebellar Cortex of the Mouse 2016 ·Journal of Comparative Pathology ·John Finnie, Peter Blumbergs, Jim Manavis	7
14	Cell adhesion molecules are altered during irinotecan-induced mucositis: a qualitative histopathological study 2016 ·Supportive Care in Cancer ·Noor Al‐Dasooqi, Joanne M. Bowen, (unknown), John Finnie, Dorothy Keefe, Rachel J. Gibson	6
15	Effect of long‐term (2 years) exposure of mouse brains to global system for mobile communication (GSM) radiofrequency fields on astrocytic immunoreactivity 2015 ·Bioelectromagnetics ·(unknown), John Finnie, Jim Manavis, Peter Blumbergs, Stephen C. Helps, Robert Vink	10
16	Pattern of cerebrospinal immediate early gene c-fos expression in an ovine model of non-accidental head injury 2013 ·Journal of Clinical Neuroscience ·John Finnie, Peter Blumbergs, Jim Manavis, Robert Vink	11
17	Upregulation of Neuronal Amyloid Precursor Protein (APP) and APP mRNA Following Magnesium Sulphate (MgSO ₄ ) Therapy in Traumatic Brain Injury 2000 ·Journal of Neurotrauma ·Cameron J. van den Heuvel, John Finnie, Peter Blumbergs, Jim Manavis, Nigel R. Jones, Peter L. Reilly, Rosemarie A. Pereira	14
18	Multifocal Cerebellar Granular Layer Necrosis in Traumatically Head-injured Lambs 1999 ·Veterinary Pathology ·John Finnie, P. C. Blumbergs, Jim Manavis	6
19	A Head Impact Model of Early Axonal Injury in the Sheep 1996 ·Journal of Neurotrauma ·Stephen B. Lewis, John Finnie, Peter Blumbergs, Grace Scott, Jim Manavis, Chris Brown, Peter L. Reilly, Nigel R. Jones, A. J. McLean	81
20	Acute hepatotoxicity with resultant pulmonary and cerebral embolism in guinea pigs given tunicamycin 1989 ·Pathology ·John Finnie, (unknown)	24

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact